Early phase collagen synthesis in lungs of rats exposed to bleomycin

Toxicology

Volumn 147, Issue 1, 2000, Pages 1-13

  Van Hoozen, Brent E ^a   Grimmer, Katharine L ^a   Marelich, Gregory P ^a   Armstrong, Lucas C ^a,b   Last, Jerold A ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bleomycin; Collagen; Lung; Pulmonary fibrosis; Silica

Indexed keywords

BLEOMYCIN; COLLAGEN TYPE 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLLAGEN SYNTHESIS; LUNG FIBROSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RAT; WOUND HEALING;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BLEOMYCIN; BLOTTING, NORTHERN; COLLAGEN; KINETICS; LUNG; MALE; PROCOLLAGEN; PULMONARY FIBROSIS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SILICON DIOXIDE;

ANIMALIA;

EID: 0034685754     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(00)00142-6     Document Type: Article

References (49)

1. Adams S.L. Collagen gene expression. Am. J. Respir. Cell Mol. Biol. 1:1989;161-168.
2. Armstrong L.C., Watkins K., Pinkerton K.E., Last J.A. Collagen mRNA content and distribution in the lungs of rats exposed to ozone. Am. J. Respir. Cell Mol. Biol. 11:1994;25-34.
3. Bateman E.D., Turner-Warwick M., Adelmann-Grill B.C. Immunohistochemical study of collagen types in human foetal lung and fibrotic lung disease. Thorax. 36:1981;645-653.
4. Bateman E.D., Turner-Warwick M., Haslam P.L., Adelmann B.C. Cryptogenic fibrosing alveolitis: prediction of fibrogenic activity from immunohistochemical studies of collagen types in lung biopsy specimens. Thorax. 38:1983;93-101.
5. Bienkowski R.S. Intracellular degradation of newly synthesized collagen. Coll. Relat. Res. 4:1984;399-411.
6. Bjermer L., Lundgren R., Hllgren R. Hyaluronan and type III procollagen peptide concentrations in bronchoalveolar lavage fluid in idiopathic pulmonary fibrosis. Thorax. 44:1989;126-131.
7. Bornstein P., Sage H. Regulation of collagen gene expression. Prog. Nucleic Acid Res. Mol. Biol. 37:1989;67-106.
8. Breen E., Shull S., Burne S., Absher M., Kelley J., Phan S., Cutroneo K.R. Bleomycin regulation of transforming growth factor-β mRNA in rat lung fibroblasts. Am. J. Respir. Cell Mol. Biol. 6:1992;146-152.
9. Cantin A.M., Boileau R., Begin R. Increased procollagen III aminoterminal peptide-related antigens and fibroblast growth signals in the lungs of patients with idiopathic pulmonary fibrosis. Am. Rev. Respir. Dis. 137:1988;572-578.
10. Chesnutt A.N., Matthay M.A., Tibayan F.A., Clark J.G. Early detection of type III procollagen peptide in acute lung injury. Pathogenetic and prognostic significance. Am. J. Respir. Crit. Care Med. 156:1997;840-845.
11. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
12. Chung E., Keele E.M., Miller E.J. Isolation and characterization of the cyanogen bromide peptides from the α1(III) chain of human collagen. Biochemistry. 13:1974;3459-3464.
13. Clark J.G., Starcher B.C., Uitto J. Bleomycin-induced synthesis of type I procollagen by human lung and skin fibroblasts in culture. Biochim. Biophys. Acta. 631:1980;359-370.
14. Clore J.N., Cohen I.K., Diegelmann R.F. Quantitation of collagen types I and III during wound healing in rat skin. Proc. Soc. Exp. Biol. Med. 161:1979;337-340.
15. Crouch E. Pathobiology of pulmonary fibrosis. Am. J. Physiol. 259(4 Pt 1):1990;L159-L184.
16. Crouch E., Persson A., Chang D., Parghi D. Surfactant Protein D. Increased accumulation in silica-induced pulmonary lipoproteinosis. Am. J. Pathol. 139:1991;765-776.
17. Crystal R.C., Ferrans V.J., Bassett F. Biologic basis of pulmonary fibrosis. Crystal R.C., West J.B., Barnes P.J., Cherniak N.S., Weibel E.R. The Lung, Scientific Foundations. 1:1991;2031-2046 Raven Press, New York, NY.
18. Cutroneo K.R., Sterling K.M. Jr. A molecular basis for bleomycin-induced pulmonary fibrosis. Chest. 89(3 Suppl):1986;121S-122S.
19. Dethloff L.A., Gilmore L.B., Brody A.R., Hook G.E. Induction of intra- and extra-cellular phospholipids in the lungs of rats exposed to silica. Biochem. J. 223:1986;111-118.
20. Epstein E.H. Jr., Scott R.D., Miller E.J., Piez K.A. Isolation and characterization of the peptides derived from soluble human and baboon skin collagen after cyanogen bromide cleavage. J. Biol. Chem. 246:1971;1718-1724.
21. Hesterberg T.W., Gerriets J.E., Reiser K.M., Jackson A.C., Cross C.E., Last J.A. Bleomycin-induced pulmonary fibrosis: correlation of biochemical, physiological, and histological changes. Toxicol. Appl. Pharmacol. 60:1981;360-367.
22. Kirk J.M.E., Heard B.E., Kerr I., Turner-Warwick M., Laurent G.J. Quantitation of types I and III collagen in biopsy lung samples from patients with cryptogenic fibrosing alveolitis. Coll. Relat. Res. 4:1984a;169-182.
23. Kirk J.M.E., Bateman E.D., Haslam P.L., Laurent G.J., Turner-Warwick M. Serum type III procollagen peptide concentration in cryptogenic fibrosing alveolitis and its clinical relevance. Thorax. 39:1984b;726-732.
24. Lammi L., Kinnula V., Lahde S., Risteli J., Paakko P., Lakari E., Ryhanen L. Propeptide levels of type III and type I procollagen in the serum and bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis. Eur. Respir. J. 10:1997;2725-2730.
25. Larjava H., Sandberg M., Happonen R.P., Vuorio E. Differential localization of type I and type III procollagen messenger ribonucleic acids in inflamed periodontal and periapical connective tissues by in situ hybridization. Lab. Invest. 62:1990;96-103.
26. Laurent G.J. Dynamic state of collagen: pathways of collagen degradation in vivo and their possible role in regulation of collagen mass. Am. J. Physiol. 252(1 Pt 1):1987;C1-C9.
27. Lehrach H., Diamond D., Wozney J.M., Boedtker H. RNA molecular weight determinations by gel electrophoresis under denaturing conditions, a critical reexamination. Biochemistry. 16:1977;4743-4751.
28. Low R.B., Cutroneo K.R., Davis G.S., Giancola M.S. Lavage type III procollagen N-terminal peptides in human pulmonary fibrosis and sarcoidosis. Lab. Invest. 48:1983;755-759.
29. Low R.B., Giancola. S., King T.E. Jr., Chapitis J., Vacek P., Davis G.S. Serum and bronchoalveolar lavage of N-terminal type III procollagen peptides in idiopathic pulmonary fibrosis. Am. Rev. Respir. Dis. 146:1992;701-706.
30. Mariani T.J., Roby J.D., Mecham R.P., Parks W.C., Crouch E., Pierce R.A. Localization of type I procollagen gene expression in silica-induced granulomatous lung disease and implication of transforming growth factor-β as a mediator of fibrosis. Am. J. Pathol. 148:1996;151-164.
31. Nerlich A.G., Nerlich M.L., Müller P.K. Pattern of collagen types and molecular structure of collagen in acute post-traumatic pulmonary fibrosis. Thorax. 42:1987;863-869.
32. Pohl W.R., Thompson A.B., Kohn H., Losch S., Umek H., Legenstein E., Kummer F., Rennard S.I., Klech H. Serum procollagen III peptide levels in subjects with sarcoidosis. Am. Rev. Respir. Dis. 145:1992;412-417.
33. Quinones F., Crouch E. Biosynthesis of interstitial and basement membrane collagens in pulmonary fibrosis. Am. Rev. Respir. Dis. 134:1986;1163-1171.
34. Raghow R., Thompson J.P. Molecular mechanisms of collagen gene expression. Mol. Cell. Biochem. 86:1989;5-18.
35. Raghu G., Striker L.J., Hudson L.D., Striker G.E. Extracellular matrix in normal and fibrotic human lungs. Am. Rev. Respir. Dis. 131:1985;281-289.
36. Reiser K.M., Hesterberg T.W., Haschek W.M., Last J.A. Experimental silicosis: 1. acute effects of intratracheally instilled quartz on collagen metabolism and morphologic characteristics of rat lungs. Am. J. Pathol. 107:1982;176-185.
37. Reiser K.M., Last J.A. Quantitation of specific collagen types from lungs of small mammals. Anal. Biochem. 104:1980;87-98.
38. Reiser K.M., Last J.A. Pulmonary fibrosis in experimental acute respiratory disease. Am. Rev. Respir. Dis. 123:1981;58-63.
39. Reiser K.M., Last J.A. Anomalous electrophoretic behavior of a cyanogen bromide peptide from type III collagen. Connect. Tissue Res. 12:1983a;1-16.
40. Reiser K.M., Last J.A. Type V collagen. Quantitation in normal lungs and in lungs of rats with bleomycin-induced pulmonary fibrosis. J. Biol. Chem. 258:1983b;269-275.
41. Reiser K.M., Last J.A. Pulmonary fibrosis. Saxena J. Pulmonary Toxicology. 1986;133-169 Hemisphere Press, Washington, DC.
42. Sambrook J., Fritsch E.F., Maniatis T. Molecular Cloning: A Laboratory Manual, second ed. 1989;Cold spring Harbor Laboratory, Cold Spring Harbor, New York.
43. Seyer J.M., Hutcheson E.T., Kang A.H. Collagen polymorphism in idiopathic chronic pulmonary fibrosis. J. Clin. Invest. 57:1976;1498-1507.
44. Shahzeidi S., Mulier B., de Crombrugghe B., Jeffery P.K., McAnulty R.J., Laurent G.J. Enhanced type III collagen gene expression during bleomycin induced lung fibrosis. Thorax. 48:1993;622-628.
45. Snider G.L., Celli B.R., Goldstein R.H., O'Brien J.J., Lucey E.C. Chronic interstitial pulmonary fibrosis produced in hamsters by endotracheal bleomycin. Lung volumes, volume-pressure relations, carbon monoxide uptake, and arterial blood gas studied. Am. Rev. Respir. Dis. 117:1978;289-297.
46. Sterling K.M. Jr., Harris M.J., Mitchell J.J., Cutroneo K.R. Bleomycin treatment of chick fibroblasts causes an increase of polysomal type I procollagen mRNAs. Reversal of the bleomycin effect by dexamethasone. J. Biol. Chem. 258:1983;14438-14444.
47. Swiderski R.E., Dencoff J.E., Floerchinger C.S., Shapiro S.D., Hunninghake G.W. Differential expression of extracellular matrix remodeling genes in a murine model of bleomycin-induced pulmonary fibrosis. Am. J. Pathol. 152:1998;821-828.
48. Thrall R.S., McCormick J.R., Jack R.M., McReynolds R.A., Ward P.A. Bleomycin-induced pulmonary fibrosis in the rat. Inhibition by indomethacin. Am. J. Pathol. 95:1979;117-130.
49. Woessner J.F. Jr. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch. Biochem. Biophys. 93:1961;440-447.